DNAnexus Stock
DNAnexus provides a global network for sharing and management of genomic data and tools to accelerate genomics. The DNAnexus cloud-based platform is optimized to address the challenges of security, scalability, and collaboration, for organizations that are pursuing genomic-based approaches to health, in the clinic and in the research lab.
Sign up for SecondMarket® to view the market and buy or sell DNAnexus Stock
Buy + SellDNAnexus Funding
Sign up to gain insights into DNAnexus funding history, including the funding round, time period, and amount raised.
Sign Up to Unlock the Data| Financing Round | Date | Amount | Price per share* | Valuation* |
|---|---|---|---|---|
| Series I | Mar 03, 2022 | 200.00M | ||
| Series H | Mar 15, 2021 | 32.15M | ||
| Series G | Jun 05, 2020 | 15.51M | ||
| Series F | Feb 06, 2019 | 14.43M | ||
| Series F | Sep 01, 2017 | 30.78M | ||
| Series E | Jan 11, 2017 | 22.45M | ||
| Series D | Apr 16, 2015 | 15.00M | ||
| Series C | Dec 20, 2013 | 15.00M | ||
| Series B | Mar 31, 2011 | 14.90M | ||
| Series A | May 13, 2009 | 1.55M |
See DNAnexus Valuations + Financials
*Sample data + company shown for illustrative purposes only
Gain insights Into DNAnexus Stock Valuation + Share Prices
View real-time Tape D® data on DNAnexus stock including most recent valuation and historical share price information.
Are you an institutional investor or employee shareholder? Sign up to the SecondMarket trading platform.
Get Started
DNAnexus Management Team
-
CTO
George Asimenos
-
Board Member
Krishna Yeshwant
-
Chief Revenue Officer
Mark Swendsen
-
Board Member
Michael D. Goldberg
-
CFO
James McNicholas
-
Chief People Officer
Kelly Green
-
Chief Cloud Officer
Omar Serang
-
CEO, Board Member
Richard T. Daly
-
President
John Ellithorpe
-
Controller
Laura Kulick
-
Board Member
Jim Tananbaum
DNAnexus Major Investors
-
WuXi PharmaTech
-
TPG Biotech
-
Northpond Ventures
-
WuXi NextCODE
-
MidCap Financial
-
Foresite Capital Management
-
Google Ventures
-
First Round Capital
-
Felicis Ventures
-
Foresite Capital
-
Regeneron Pharmaceuticals
-
Tarrant Capital IP
-
Blackstone Growth (BXG)
-
Perceptive Advisors
-
Capital Partners
-
M12 (Microsoft Ventures)
-
Innovatus Capital Partners
-
TPG Capital
-
Claremont Creek Ventures
Learn More About DNAnexus Stock
Buy DNAnexus Stock
01DNAnexus stock does not trade on public stock exchanges. DNAnexus stock is considered a private security and you need to be an accredited investor to trade shares. To invest in DNAnexus stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Sell DNAnexus Stock
02DNAnexus Stock does not trade on public stock exchanges. In order to sell DNAnexus shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
DNAnexus Stock Price
03DNAnexus does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the Tape D™ database from Nasdaq Private Market, you can view DNAnexus share price and other valuable private market data.
Read more about secondary market private company stock prices:
DNAnexus Stock Ticker Symbol
04There is no ticker symbol for DNAnexus stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Criteria to Sell DNAnexus Stock
05Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell DNAnexus stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Criteria to Buy or Invest in DNAnexus Stock
06Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in DNAnexus stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
DNAnexus Stock Settlement
07Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
DNAnexus IPO
08DNAnexus is a private company and has not had an IPO. There is currently no DNAnexus IPO price. Get started to begin exploring the Nasdaq Private Market Tape D™ database and gain access to actionable data related to DNAnexus IPO.
Learn more about Tape D™ private company stock data for institutional investors on the on the Tape D™ Product Page.
Sign up for SecondMarket® to view the market and buy or sell DNAnexus Stock
Buy + Sell*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.
